• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道来源感染发病机制中的微生物群-免疫相互作用。

Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection.

机构信息

Research Institute of General Surgery, Jinling Hospital, Medical School, Nanjing University, Nanjing, China.

出版信息

Front Immunol. 2019 Aug 7;10:1873. doi: 10.3389/fimmu.2019.01873. eCollection 2019.

DOI:10.3389/fimmu.2019.01873
PMID:31456801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6698791/
Abstract

Gut-derived infection is among the most common complications in patients who underwent severe trauma, serious burn, major surgery, hemorrhagic shock or severe acute pancreatitis (SAP). It could cause sepsis and multiple organ dysfunction syndrome (MODS), which are regarded as a leading cause of mortality in these cases. Gut-derived infection is commonly caused by pathological translocation of intestinal bacteria or endotoxins, resulting from the dysfunction of the gut barrier. In the last decades, the studies regarding to the pathogenesis of gut-derived infection mainly focused on the breakdown of intestinal epithelial tight junction and increased permeability. Limited information is available on the roles of intestinal microbial barrier in the development of gut-derived infection. Recently, advances of next-generation DNA sequencing techniques and its utilization has revolutionized the gut microecology, leading to novel views into the composition of the intestinal microbiota and its connections with multiple diseases. Here, we reviewed the recent progress in the research field of intestinal barrier disruption and gut-derived infection, mainly through the perspectives of the dysbiosis of intestinal microbiota and its interaction with intestinal mucosal immune cells. This review presents novel insights into how the gut microbiota collaborates with mucosal immune cells to involve the development of pathological bacterial translocation. The data might have important implication to better understand the mechanism underlying pathological bacterial translocation, contributing us to develop new strategies for prevention and treatment of gut-derived sepsis.

摘要

肠源性感染是严重创伤、严重烧伤、大手术、失血性休克或重症急性胰腺炎(SAP)患者最常见的并发症之一。它可导致脓毒症和多器官功能障碍综合征(MODS),这被认为是这些情况下死亡的主要原因。肠源性感染通常是由肠道细菌或内毒素的病理移位引起的,这是由于肠道屏障功能障碍所致。在过去的几十年中,关于肠源性感染发病机制的研究主要集中在肠上皮紧密连接的破坏和通透性增加上。关于肠道微生物屏障在肠源性感染发展中的作用的信息有限。最近,下一代 DNA 测序技术的进步及其应用彻底改变了肠道微生态学,为肠道微生物群的组成及其与多种疾病的关系提供了新的视角。在这里,我们综述了肠道屏障破坏和肠源性感染研究领域的最新进展,主要是通过肠道微生物失调及其与肠道黏膜免疫细胞的相互作用的角度。这篇综述为肠道微生物群如何与黏膜免疫细胞合作参与病理性细菌易位的发展提供了新的见解。这些数据可能对更好地理解病理性细菌易位的机制具有重要意义,并有助于我们开发预防和治疗肠源性脓毒症的新策略。

相似文献

1
Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection.肠道来源感染发病机制中的微生物群-免疫相互作用。
Front Immunol. 2019 Aug 7;10:1873. doi: 10.3389/fimmu.2019.01873. eCollection 2019.
2
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
3
Role of gut microbiota on intestinal barrier function in acute pancreatitis.肠道微生物群在急性胰腺炎肠屏障功能中的作用。
World J Gastroenterol. 2020 May 14;26(18):2187-2193. doi: 10.3748/wjg.v26.i18.2187.
4
The role and therapeutic potential of gut microbiome in severe burn.肠道微生物组在严重烧伤中的作用和治疗潜力。
Front Cell Infect Microbiol. 2022 Nov 17;12:974259. doi: 10.3389/fcimb.2022.974259. eCollection 2022.
5
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.肠道渗漏综合征的伙伴:肠道菌群失调与自身免疫。
Front Immunol. 2021 Apr 22;12:673708. doi: 10.3389/fimmu.2021.673708. eCollection 2021.
6
Interaction between the gut microbiome and mucosal immune system.肠道微生物组与黏膜免疫系统的相互作用。
Mil Med Res. 2017 Apr 27;4:14. doi: 10.1186/s40779-017-0122-9. eCollection 2017.
7
Gut promotes protective immunity to foodborne infection.肠道促进食物源性感染的保护性免疫。
Microbiol Spectr. 2024 Oct 3;12(10):e0402523. doi: 10.1128/spectrum.04025-23. Epub 2024 Aug 27.
8
Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.肠道微生物失调和炎症性肠病及结直肠癌的屏障功能障碍:探索一个共同的基础假说。
J Biomed Sci. 2018 Nov 9;25(1):79. doi: 10.1186/s12929-018-0483-8.
9
Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.肠道菌群失调驱动的免疫失调促进肝硬化大鼠的屏障破坏和细菌易位。
Hepatology. 2019 Sep;70(3):925-938. doi: 10.1002/hep.30349. Epub 2019 Mar 5.
10
The leaky gut and the gut microbiome in sepsis - targets in research and treatment.肠漏和脓毒症中的肠道微生物组——研究和治疗的靶点。
Clin Sci (Lond). 2023 Apr 26;137(8):645-662. doi: 10.1042/CS20220777.

引用本文的文献

1
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.从毒素到治疗:环境污染物、肠道微生物群和天然化合物对非酒精性脂肪性肝病进展的影响
World J Hepatol. 2025 Aug 27;17(8):108772. doi: 10.4254/wjh.v17.i8.108772.
2
Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection.多重耐药菌定植和感染的危重症患者的肠道微生物群失调与全身免疫功能障碍
J Transl Med. 2025 Sep 2;23(1):981. doi: 10.1186/s12967-025-07049-2.
3
Gut Microbiota Metabolites Targeting the Immune Response in Sepsis: Mechanisms and Therapies.靶向脓毒症免疫反应的肠道微生物群代谢产物:机制与疗法
Int J Gen Med. 2025 Aug 25;18:4709-4734. doi: 10.2147/IJGM.S539237. eCollection 2025.
4
Shenfu injection promotes self-renewal of intestinal stem cells in sepsis-induced intestinal injury via inducing ATF4 expression.参附注射液通过诱导ATF4表达促进脓毒症诱导的肠损伤中肠干细胞的自我更新。
Front Pharmacol. 2025 Jul 31;16:1500157. doi: 10.3389/fphar.2025.1500157. eCollection 2025.
5
Epidemiology, clinical characteristics, and outcome of enterococcal bloodstream infections in critically ill patients in China: a single-center retrospective 10-year analysis.中国重症患者肠球菌血流感染的流行病学、临床特征及转归:一项单中心10年回顾性分析
Microbiol Spectr. 2025 Sep 2;13(9):e0106725. doi: 10.1128/spectrum.01067-25. Epub 2025 Aug 11.
6
High-fat and low-fiber diet elevates the gut resistome: a comparative metagenomic study.高脂低纤维饮食会提升肠道耐药菌基因组:一项比较宏基因组学研究。
NPJ Biofilms Microbiomes. 2025 Aug 9;11(1):156. doi: 10.1038/s41522-025-00799-3.
7
Novel insights into ORFV B2L DNA vaccine-mediated gut microbiota modulation and immune augmentation in rats.对羊口疮病毒B2L DNA疫苗介导的大鼠肠道微生物群调节和免疫增强的新见解。
Front Immunol. 2025 Jul 18;16:1598969. doi: 10.3389/fimmu.2025.1598969. eCollection 2025.
8
Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger.尼日尔患有严重急性营养不良的住院儿童获得携带超广谱β-内酰胺酶和碳青霉烯酶基因的大肠杆菌。
Nat Commun. 2025 Aug 1;16(1):6751. doi: 10.1038/s41467-025-61718-w.
9
A Mechanistic Approach to Replacing Antibiotics with Natural Products in the Treatment of Bacterial Diarrhea.一种用天然产物替代抗生素治疗细菌性腹泻的机制性方法。
Biomolecules. 2025 Jul 18;15(7):1045. doi: 10.3390/biom15071045.
10
Molecular mechanisms and functions of protein acetylation in sepsis and sepsis-associated organ dysfunction.脓毒症及脓毒症相关器官功能障碍中蛋白质乙酰化的分子机制与功能
Cell Mol Biol Lett. 2025 Jul 26;30(1):91. doi: 10.1186/s11658-025-00773-z.

本文引用的文献

1
The gut virome: the 'missing link' between gut bacteria and host immunity?肠道病毒组:肠道细菌与宿主免疫之间的“缺失环节”?
Therap Adv Gastroenterol. 2019 Mar 25;12:1756284819836620. doi: 10.1177/1756284819836620. eCollection 2019.
2
β-Defensins: Farming the Microbiome for Homeostasis and Health.β-防御素:从微生物组中获取体内平衡和健康的方法。
Front Immunol. 2019 Jan 25;9:3072. doi: 10.3389/fimmu.2018.03072. eCollection 2018.
3
Gut microbiota in patients after surgical treatment for colorectal cancer.结直肠癌患者手术后的肠道微生物群。
Environ Microbiol. 2019 Feb;21(2):772-783. doi: 10.1111/1462-2920.14498. Epub 2018 Dec 19.
4
Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.肠道微生物失调会加重患者和小鼠急性胰腺炎的严重程度。
J Gastroenterol. 2019 Apr;54(4):347-358. doi: 10.1007/s00535-018-1529-0. Epub 2018 Dec 5.
5
A Pilot Study: Changes of Gut Microbiota in Post-surgery Colorectal Cancer Patients.一项试点研究:手术后结直肠癌患者肠道微生物群的变化
Front Microbiol. 2018 Nov 20;9:2777. doi: 10.3389/fmicb.2018.02777. eCollection 2018.
6
Biology and Taxonomy of crAss-like Bacteriophages, the Most Abundant Virus in the Human Gut.肠道 crAss 样噬菌体的生物学与分类学研究,此类噬菌体是人肠道内最丰富的病毒。
Cell Host Microbe. 2018 Nov 14;24(5):653-664.e6. doi: 10.1016/j.chom.2018.10.002. Epub 2018 Oct 25.
7
Efficacy of different faecal microbiota transplantation protocols for infection: A systematic review and meta-analysis.不同粪便微生物群移植方案治疗感染的疗效:一项系统评价和荟萃分析。
United European Gastroenterol J. 2018 Oct;6(8):1232-1244. doi: 10.1177/2050640618780762. Epub 2018 Jun 3.
8
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.肠道微生物群在预防和治疗脓毒症中的治疗潜力。
Front Immunol. 2018 Sep 10;9:2042. doi: 10.3389/fimmu.2018.02042. eCollection 2018.
9
The gut microbiota of critically ill patients: first steps in an unexplored world.重症患者的肠道微生物群:探索未知领域的初步进展
Intensive Care Med. 2018 Sep;44(9):1561-1564. doi: 10.1007/s00134-018-5309-3. Epub 2018 Jul 14.
10
Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection.重症监护病房入住时胃肠道微生物组的病原体定植与随后的死亡或感染风险。
Intensive Care Med. 2018 Aug;44(8):1203-1211. doi: 10.1007/s00134-018-5268-8. Epub 2018 Jun 23.